Drugs / Menhycia
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07710872 Comparator | Aug 2026 → Mar 2028 expected | meningococcal infection | Sanofi | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Menhycia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07710872 ↗ |
| Modality | Vaccine | “ACYW135 Meningococcal Conjugate Vaccine [CRM197]” NCT07710872 ↗ |
| Route | Intramuscular | “Route of administration:IM injection” NCT07710872 ↗ |